论文部分内容阅读
康莱特注射液于1995年获国家二类新药证书和生产批准文号，获中国和美国专利证书。抗癌中药“康莱特注射剂”是应用现代高新科学技术从传统抗癌中药中提取精制而成的，可供静脉（或动脉插管）输往的乳剂。该制剂不仅能使中药直接作用于癌细胞，而且还具有高能量营养，是目前国
Kanglaite Injection won the national second-class new drug certificate and production approval number in 1995 and has obtained Chinese and U.S. patent certificates. Anti-cancer Chinese medicine “KLT injection” is a kind of emulsion that is extracted and purified from traditional anti-cancer medicines using modern high-tech science and technology, and can be sent to the vein (or arterial cannula). The preparation not only enables Chinese medicine to directly act on cancer cells, but also has high energy nutrition and is the current state